Skip to main content
SpringerLink
Log in

Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluid

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Twelve patients suffering from rheumatoid arthritis and having swollen knees were treated with 1.1 g/day of sodium naproxen administered in one dose, daily for 5 days.

The 72-h wash-out period was verified by the absence of any nonsteroidal anti-inflammatory drug using a HPLC screening. Blood and synovial fluid samples were drawn just before treatment and 24 h after the last dose.

Eicosanoids (PGE2, 6-keto-PGF1α, TXB2, LTB4, LTC4) in synovial fluid were determined by immunoenzy-matic assays. In plasma and synovial fluid, hyaluronic acid was assayed by radiometric assay and sodium naproxen by HPLC. Free drug was determined by equilibrium dialysis. Statistical analysis used nonparametric tests.

Pain relief (evaluated on a visual scale), morning stiffness, and scores on the Lee and Ritchie indices all decreased significantly, as did PGE2 and LTB4 concentrations. The decrease in 6-keto-PGF1α and TXB2 was not significant. No significant change was found for LTC4 and hyaluronic acid.

Total concentrations of sodium naproxen were equivalent in plasma (16.1 μg·ml−1) and synovial fluid (18.9 μg·ml−1). Free fractions were significantly higher in synovial fluid (0.14%) than in plasma (0.11 %), as shown by binding of the drug to human serum albumin, at various protein concentrations.

Interestingly, the clinical efficacy, as shown by decreases in morning stiffness and in the Lee index score, correlated with the free concentration of naproxen in synovial fluid.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bruno R, Iliadis A, Jullien I, Guego M, Pinhas H, Cunci S, Cano J (1988) Naproxen kinetics in synovial fluid of patients with osteoarthritis. Br J Clin Pharmacol 26: 41–44

    Google Scholar 

  • Caillier I, Bannwarth B, Monot C, Lapicque F, Netter P, Gaucher A, Royer RJ (1990) Differences in sodium salicylate protein binding in serum and synovial fluid from patients with a knee effusion. Int J Clin Pharmacol Ther Toxicol 28: 7–13

    Google Scholar 

  • Chichibu K, Matsuura T, Shichijo S, Yokoyama M (1989) Assay of serum hyaluronic acid in clinical application. Clin Chim Acta 181: 317–324

    Google Scholar 

  • Day R, Furst D, Dromgoole S, Kamm B, Roe R, Paulus H (1982) Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis. Clin Pharmacol Ther 31: 733–740

    Google Scholar 

  • Dougados M, Coste P, Stalla-Bourdillon A, Amor B (1986) Influence de la nature de l'épanchement articulaire sur la diffusion des anti-inflammatoires non stéroïdiens à travers la membrane synoviale: à propos du naproxène sodique 550 mg au cours de la polyarthrite rhumatoïde et la gonarthrose. Rev Int Rheumatol 16: 105–109

    Google Scholar 

  • Engstrom-Laurent A (1989) Changes in hyaluronan concentration in tissues and body fluids in disease states. In: Evered D, Whelan J (eds) The biology of hyaluronan. (Ciba Foundation symposium 143) Wiley, Chichester, pp 233–247

    Google Scholar 

  • Forster RT, Jamali F, Russel AS, Alballa SR (1988) Pharmacokinetics of ketoprofen enantiomers in young and elderly arthritic patients following single and multiple doses. J Pharm Sci 77: 191–195

    Google Scholar 

  • Foster RT, Jamali F, Russel AS (1989) Ketoprofen enantiomers in synovial fluid. J Pharm Sci 78: 881–882

    Google Scholar 

  • Franssen M, Tan Y, Van de Putte L, Ginneken C, Gribnau F (1986) Pharmacokinetics of naproxen at two dosage regimens in healthy volunteers. Int J Clin Pharmacol Ther Toxicol 24: 139–142

    Google Scholar 

  • Gougeon F, Duquennoy A, Fontaine C, Bailleul F (1989) Etude des concentrations du naproxène sodique dans la membrane synoviale, le liquide synovial et le cartilage articulaire. Rev Int Rheumatol 19: 2–7

    Google Scholar 

  • Jalava S, Saarimaa H, Anttila M, Sundquist H (1977) Naproxen concentrations in serum, synovial fluid and synovium. Scand J Rheumatol 6: 155–157

    Google Scholar 

  • Jouzeau JY, Payan E, Gillet P, Péré P, Netter P, Gaucher A (1992) Clinical significance of hyaluronan in rheumatic disease: comment on the articles by Goldberg et al. and Woessner. Arthritis Rheum 35: 1253–1254

    Google Scholar 

  • Lapicque F, Netter P, Bannwarth B, Tréchot P, Gillet P, Lambert H, Royer RJ (1989) Identification and simultaneous determination of non-steroidal anti-inflammatory drugs using high-performance liquid chromatography. J Chromatogr 496: 301–320

    Google Scholar 

  • Lee P, Jasani MK, Dick NC, Buchanan WW (1973) Evaluation of a functional index in rheumatoid arthritis. Scand J Rheumatol 2: 71–77

    Google Scholar 

  • Lin JH, Cochetto DM, Duggan DE (1987) Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs. Clin Pharmacokinet 12: 402–432

    Google Scholar 

  • Maclouf J, Grassi J, Pradelles P (1987) Development of enzyme-immunoassay techniques for measurement of eicosanoids in prostaglandins and lipid metabolism injury. In: Walden TL, Hughes HN (eds) Proceedings of the International Conference on Prostaglandins and Lipid Metabolism in Radiation Injury. Plenum Press, New York, pp 355–364

    Google Scholar 

  • Marshall L, Bauer J, Sung M, Chang J (1991) Evaluation of antirheumatic drugs for their effect in vitro on purified human synovial fluid phospholipase A2. J Rheumatol 1: 59–65

    Google Scholar 

  • Mathieu P, Benzoni D, Fontanges E, Vignon E (1988) Etude de l'action du kétoprofène sur les prostaglandines primaires du liquide synovial dans la polyarthrite rhumatoïde. Rhumatologie 40: 223–228

    Google Scholar 

  • Meyer F, Yaron I, Mashiah V, Yaron M (1989) Effect of diclofenac on prostaglandin E and hyaluronic acid production by human synovial fibroblasts stimulated with interleukin 1. Br J Clin Pharmacol 28: 193–196

    Google Scholar 

  • Mortensen A, Jensen E, Petersen P, Husted S, Andreasen F (1979) The determination of naproxen by spectrofluorimetry and its binding to serum proteins. Acta Pharmacol Toxicol 44: 277–283

    Google Scholar 

  • Muller N, Payan E, Lapicque F, Bannwarth B, Netter P (1990) Pharmacological aspects of chiral nonsteroidal anti-inflammatory drugs. Fundam Clin Pharmacol 4: 617–634

    Google Scholar 

  • Netter P, Monot C, Stalars M, Mur J, Royer RJ (1984) Decrease of in vitro serum protein binding of salicylate in rheumatoid arthritis. Eur J Drug Metab Pharm 9: 109–116

    Google Scholar 

  • Netter P, Faure G, Régent M, Procknal J, Levy G (1985) Salicylate kinetics in old age. Clin Pharmacol Ther 38: 6–11

    Google Scholar 

  • Netter P, Bannwarth B, Royer-Morrot MJ (1989) Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid. Clin Pharmacokinet 17: 145–162

    Google Scholar 

  • Netter P, Bannwarth B, Lapicque F, Abiteboul M, Lequintrec JS, Dousset B, Péré P, Gaucher A (1993) Influence of synovial fluid concentration of ketoprofen on PGE2 and arthritic pain. Clin Pharmacol Ther 53: 152

    Google Scholar 

  • Ogilvie-Harris DJ, Bauer M, Corey P (1985) Prostaglandin inhibition and the rate of recovery after arthroscopic meniscectomy. J Bone Joint Surg Br 67: 567–571

    Google Scholar 

  • O'Neill L, Lewis G (1989) Inhibitory effects of diclofenac and indomethacin on interleukin-1 — induced changes in PGE2 release. A novel effect on free arachidonic acid levels in human synovial cells. J Rheumatol 8: 1160–1161

    Google Scholar 

  • Payan E, Jouzeau JY, Lapicque F, Muller N, Payan JP, Gegout P, Bertin P, Netter P (1991) Assay of synovial fluid hyaluronic acid using HPLC of hyaluronidase digests. J Chromatogr 566: 9–18

    Google Scholar 

  • Pradelles P, Grassi J, Maclouf J (1985) Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal Chem 57: 1170–1173

    Google Scholar 

  • Pradelles P, Grassi J, Maclouf J (1990a) Enzyme immunoassays of eicosanoids using acetylcholinesterase. In: Murphy RC, Fitzpatrick FA (eds) Methods in enzymology, vol 187. Academic Press, pp 24–34

  • Pradelles P, Antoine C, Lellouche JP, Maclouf J (1990b) Enzyme immunoassays for leukotrienes C4 and E4 using acetylcholinesterase. In: Murphy RC, Fitzpatrick FA (eds) Methods in enzymology, vol 187. Academic Press, London, pp 82–89

    Google Scholar 

  • Rendic S, Alebic-Kolbah T, Kajfez F (1981) Binding of piroxicam to human serum albumin. Acta Pharm Jugoslav 31: 215–220

    Google Scholar 

  • Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TC, Grieveson P, Buchanan WW (1968) Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 37: 394–406

    Google Scholar 

  • Runkel R, Chaplin M, Boost G, Segre E, Forchielle E (1972) Absorption, distribution, metabolism and excretion of naproxen in various laboratory animals and human subjects. J Pharm Sci 61: 703–708

    Google Scholar 

  • Runkel R, Forchielli E, Sevelius H, Chaplin M, Segre E (1973) Nonlinear plasma level response to high dose of naproxen. Clin Pharmacol Ther 15: 261–266

    Google Scholar 

  • Seppala E, Nissila M, Isomaki H, Wuorela H, Vapaatalo H (1990) Effects of non-steroidal anti-inflammatory drugs and prednisolone on synovial fluid white cells, prostaglandin E2, leucotriene B4 and cyclic AMP in patients with rheumatoid arthritis. Scand J Rheumatol 19: 71–75

    Google Scholar 

  • Sevelius H, Runkel R, Segre E, Bloomfield SS (1980) Bioavailability of naproxen sodium and its relationship to clinical analgesic effects. Br J Clin Pharmacol 10: 259–263

    Google Scholar 

  • Upton RA, Kelly WJ, Jones RM (1984) Naproxen pharmacokinetics in the elderly. Br J Clin Pharmacol 18: 207–214

    Google Scholar 

  • Urquhart E (1991) A comparison of synovial fluid concentrations of non-steroidal anti-inflammatory drugs with their in vitro activity. Agents Actions 32: 261–265

    Google Scholar 

  • Vanwimolruk S, Brooks P, Birkett J (1983) Protein binding of non-steroidal anti-inflammatory drugs in plasma and synovial fluid of arthritic patients. Br J Clin Pharmacol 15: 91–94

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinique Thérapeutique et Rhumatologique, Hôpital Universitaire Dupuytren, Limoges Cedex, France

    P. Bertin & R. Treves

  2. Faculté de Médecine, Laboratoire de Pharmacologie, URA CNRS 1288, Vandoeuvre les Nancy, France

    F. Lapicque, E. Payan & P. Netter

  3. Faculté de Médecine, Laboratoire de Biochimie, URA CNRS 1485, Limoges Cedex, France

    M. Rigaud

  4. Recherche Syntex France (Paris), Puteaux, France

    F. Bailleul & S. Jaeger

Authors
  1. P. Bertin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Lapicque
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Payan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Rigaud
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Bailleul
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Jaeger
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. Treves
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P. Netter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bertin, P., Lapicque, F., Payan, E. et al. Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluid. Eur J Clin Pharmacol 46, 3–7 (1994). https://doi.org/10.1007/BF00195907

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00195907

Key words

Search

Navigation